$GH

$173.25 +$4.17 (2.47%) Close

$GH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$GH Management Team

Dr. Helmy Eltoukhy

Chairperson of the Board

Co-Chief Executive Officer

Age 46

Compensation $11.61M USD

Sex Male

Dr. Amirali Talasaz

Co-Chief Executive Officer

Director

Age 45

Compensation $11.61M USD

Sex Male

Mr. Michael Bell

Chief Financial Officer

Age 56

Compensation $3.607M USD

Sex Male

Ms. Terilyn Monroe

Chief People Officer

Age 58

Compensation $5.519M USD

Sex Female

Mr. Kumud Kalia

Chief Information Officer

Age 59

Compensation -

Sex Male

Dr. Craig Eagle

Chief Medical Officer

Age 58

Compensation $3.485M USD

Sex Male

Mr. Christopher Freeman

Chief Commercial Officer

Age 51

Compensation $3.523M USD

Sex Male

Mr. John Saia

Chief Legal Officer

Corporate Secretary

Age 52

Compensation $3.203M USD

Sex Male

Dr. Darya Chudova

Chief Technology Officer

Age 51

Compensation $3.476M USD

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Helmy Eltoukhy Chairperson of the Board Co-Chief Executive Officer	46	$11.61M USD	Male
Dr. Amirali Talasaz Co-Chief Executive Officer Director	45	$11.61M USD	Male
Mr. Michael Bell Chief Financial Officer	56	$3.607M USD	Male
Ms. Terilyn Monroe Chief People Officer	58	$5.519M USD	Female
Mr. Kumud Kalia Chief Information Officer	59	-	Male
Dr. Craig Eagle Chief Medical Officer	58	$3.485M USD	Male
Mr. Christopher Freeman Chief Commercial Officer	51	$3.523M USD	Male
Mr. John Saia Chief Legal Officer Corporate Secretary	52	$3.203M USD	Male
Dr. Darya Chudova Chief Technology Officer	51	$3.476M USD	Female

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

9 of 11

stated in the proxy

Average tenure

5.0 years

from year joined

CEO also chairs the board

Yes

Helmy Eltoukhy

Director	Age	On board	Independent	Committees	Other public boards	Pay
Ian Clark Lead independent director	Not stated	2017 9 years	Independent	Governance Committee · Chair	Takeda Pharmaceutical Company Limited	$470,242
Manuel Hidalgo Medina	Not stated	2024 2 years	Independent	Nominating and Corporate Governance Committee	Bristol-Myers Squibb Company	$425,286
Meghan Joyce Leaving at the meeting	Not stated	Not stated	Independent	Audit Committee	None stated	$425,286
Alex M. Azar II	Not stated	2025 1 year	Independent	Nominating and Corporate Governance Committee	None stated	$725,332
Helmy Eltoukhy Board chair, CEO	Not stated	2013 13 years	Not independent	None stated	None stated	Paid as CEO
Steve Krognes	Not stated	2022 4 years	Independent	Audit Committee · Chair	Denali Therapeutics Inc., argenx SE, Pliant Therapeutics, Inc.	$425,286
AmirAli Talasaz CEO	Not stated	Not stated	Not independent	None stated	None stated	Paid as CEO
Vijaya Gadde	Not stated	2020 6 years	Independent	Compensation Committee · Chair	Planet Labs PBC	$425,286
Roberto Mignone	Not stated	2024 2 years	Independent	Audit Committee	Teva Pharmaceuticals	$425,286
Myrtle Potter	Not stated	2021 5 years	Independent	Audit Committee	Opentrons Labworks, Inc.	$425,286
Musa Tariq	Not stated	2023 3 years	Independent	None stated	None stated	$425,286

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$GH Management Team

Dr. Helmy Eltoukhy

Dr. Amirali Talasaz

Mr. Michael Bell

Ms. Terilyn Monroe

Mr. Kumud Kalia

Dr. Craig Eagle

Mr. Christopher Freeman

Mr. John Saia

Dr. Darya Chudova

Board of Directors

Related-party transactions

No related-party transactions disclosed